Publications

How Do You Know Which Health Care Effectiveness Research You Can Trust? A Guide to Study Design for the Perplexed.

Prev Chronic Dis
Soumerai SB, Starr D, Majumdar SR

Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations? A Time-Series Analysis.

Ann. Intern. Med.
Briesacher BA, Madden JM, Zhang F, Fouayzi H, Ross-Degnan D, Gurwitz JH, Soumerai SB

Impact of Medicare's Hospital-Acquired Condition policy on infections in safety net and non-safety net hospitals.

Infect Control Hosp Epidemiol
Vaz LE, Kleinman KP, Kawai AT, Jin R, Kassler WJ, Grant PS, Rett MD, Goldmann DA, Calderwood MS, Soumerai SB, Lee GM

Evaluating diabetes health policies using natural experiments: the natural experiments for translation in diabetes study.

Am J Prev Med
Ackermann RT, Kenrik Duru O, Albu JB, Schmittdiel JA, Soumerai SB, Wharam JF, Ali MK, Mangione CM, Gregg EW,

Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene Inhibitors.

Clin Ther
Lu CY, Zhang F, Lakoma MD, Butler MG, Fung V, Larkin EK, Kharbanda EO, Vollmer WM, Lieu T, Soumerai SB, Chen Wu A

Effects of eliminating drug caps on racial differences in antidepressant use among dual enrollees with diabetes and depression.

Clin Ther
Adams AS, Soumerai SB, Zhang F, Gilden D, Burns M, Huskamp HA, Trinacty C, Alegria M, LeCates RF, Griggs JJ, Ross-Degnan D, Madden JM

A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation.

J Clin Epidemiol
Fretheim A, Zhang F, Ross-Degnan D, Oxman AD, Cheyne H, Foy R, Goodacre S, Herrin J, Kerse N, McKinlay RJ, Wright A, Soumerai SB

Primary adherence to controller medications for asthma is poor.

Ann Am Thorac Soc
Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Miroshnik I, Davis RL, Lieu TA, Soumerai SB

Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.

JAMA Psychiatry
Madden JM, Adams AS, LeCates RF, Ross-Degnan D, Zhang F, Huskamp HA, Gilden DM, Soumerai SB

Instrumental variable analyses for observational comparative effectiveness research: the paired availability design.

Ann. Intern. Med.
Garabedian LF, Zaslavsky AM, Soumerai SB

Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011.

Med Care
Naci H, Soumerai SB, Ross-Degnan D, Zhang F, Briesacher BA, Gurwitz JH, Madden JM

Authors' reply to Mosholder and colleagues.

BMJ
Lu CY, Simon G, Soumerai SB

Authors' reply to Olfson and Schoenbaum, Nardo, Bartlett, Moore, Case, Gøtzsche, and Barber and colleagues.

BMJ
Lu CY, Simon G, Soumerai SB

Medication affordability gains following Medicare Part D are eroding among elderly with multiple chronic conditions.

Health Aff (Millwood)
Naci H, Soumerai SB, Ross-Degnan D, Zhang F, Briesacher BA, Gurwitz JH, Madden JM

Changes in use of lipid-lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage.

Med Care
Adams AS, Madden JM, Zhang F, Soumerai SB, Gilden D, Griggs J, Trinacty CM, Bishop C, Ross-Degnan D

Potential bias of instrumental variable analyses for observational comparative effectiveness research.

Ann. Intern. Med.
Garabedian LF, Chu P, Toh S, Zaslavsky AM, Soumerai SB

National prevalence of receipt of antidepressant prescriptions by persons without a psychiatric diagnosis.

Psychiatr Serv
Simon GE, Stewart C, Beck A, Ahmedani BK, Coleman KJ, Whitebird RR, Lynch F, Owen-Smith AA, Waitzfelder BE, Soumerai SB, Hunkeler EM

Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study.

BMJ
Lu CY, Zhang F, Lakoma MD, Madden JM, Rusinak D, Penfold RB, Simon G, Ahmedani BK, Clarke G, Hunkeler EM, Waitzfelder B, Owen-Smith A, Raebel MA, Rossom R, Coleman KJ, Copeland LA, Soumerai SB

Effects of Medicare Part D on guideline-concordant pharmacotherapy for bipolar I disorder among dual beneficiaries.

Psychiatr Serv
Burns ME, Busch AB, Madden JM, Le Cates RF, Zhang F, Adams AS, Ross-Degnan D, Soumerai SB, Huskamp HA

How complete are E-codes in commercial plan claims databases?

Pharmacoepidemiol Drug Saf
Lu CY, Stewart C, Ahmed AT, Ahmedani BK, Coleman K, Copeland LA, Hunkeler EM, Lakoma MD, Madden JM, Penfold RB, Rusinak D, Zhang F, Soumerai SB